<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Seo JE</submitter><funding>Center for Drug Evaluation and Research</funding><funding>Intramural FDA HHS</funding><pagination>111538</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12441990</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>416</volume><pubmed_abstract>N-nitrosamines have been increasingly detected in human drugs, raising serious safety concerns due to their potential mutagenicity and carcinogenicity. In order to expand upon the human data available on these drug impurities, we previously used metabolically competent HepaRG human hepatoma cells to evaluate the genotoxicity of eight small-molecule nitrosamines [N-cyclopentyl-4-nitrosopiperazine (CPNP), N-nitrosodibutylamine (NDBA), N-nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-nitrosodiisopropylamine (NDIPA), N-nitrosoethylisopropylamine (NEIPA), N-nitroso-N-methyl-4-aminobutyric acid (NMBA), and N-nitrosomethylphenylamine (NMPA)]. In this study, we used the comet assay to further investigate the DNA damage induced by the eight nitrosamines in primary human hepatocytes (P</pubmed_abstract><journal>Chemico-biological interactions</journal><pubmed_title>Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes.</pubmed_title><pmcid>PMC12441990</pmcid><funding_grant_id>FD999999</funding_grant_id><pubmed_authors>McGovern TJ</pubmed_authors><pubmed_authors>Bryant M</pubmed_authors><pubmed_authors>Atrakchi AH</pubmed_authors><pubmed_authors>Guo X</pubmed_authors><pubmed_authors>He X</pubmed_authors><pubmed_authors>Seo JE</pubmed_authors><pubmed_authors>Heflich RH</pubmed_authors><pubmed_authors>Davis Bruno KL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Comparative DNA damage induced by eight nitrosamines in primary human and macaque hepatocytes.</name><description>N-nitrosamines have been increasingly detected in human drugs, raising serious safety concerns due to their potential mutagenicity and carcinogenicity. In order to expand upon the human data available on these drug impurities, we previously used metabolically competent HepaRG human hepatoma cells to evaluate the genotoxicity of eight small-molecule nitrosamines [N-cyclopentyl-4-nitrosopiperazine (CPNP), N-nitrosodibutylamine (NDBA), N-nitrosodiethylamine (NDEA), N-nitrosodimethylamine (NDMA), N-nitrosodiisopropylamine (NDIPA), N-nitrosoethylisopropylamine (NEIPA), N-nitroso-N-methyl-4-aminobutyric acid (NMBA), and N-nitrosomethylphenylamine (NMPA)]. In this study, we used the comet assay to further investigate the DNA damage induced by the eight nitrosamines in primary human hepatocytes (P</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-03T11:21:20.133Z</modification><creation>2026-05-29T03:06:07.637Z</creation></dates><accession>S-EPMC12441990</accession><cross_references><pubmed>40319998</pubmed><doi>10.1016/j.cbi.2025.111538</doi></cross_references></HashMap>